
61.76 BATS BZX Real-Time Price As of 3:32pm ET | ![]() Today’s Change | 45.76 Today|||52-Week Range 67.16 | -0.44% Year-to-Date |
3 Top Stocks That'll Make You Richer in March (and Beyond) 5:51am / MotleyFool.com - Paid Partner Content | Nektar (NKTR) Q4 Earnings and Revenues Top, Pipeline On Track Feb 26 / Zacks.com - Paid Partner Content |
Retail, Tech Earnings, and Berkshire's Surprising Buys Feb 27 / MotleyFool.com - Paid Partner Content | FATE Reports Wider-Than-Expected Q4 Loss on Higher Expenses Feb 25 / Zacks.com - Paid Partner Content |
Buy This Blue Chip on the Dip Feb 26 / MotleyFool.com - Paid Partner Content | bluebird (BLUE) Q4 Loss Narrower than Expected, Sales Miss Feb 24 / Zacks.com - Paid Partner Content |
Iovance (IOVA) Q4 Earnings Miss Estimates, Pipeline in Focus Feb 26 / Zacks.com - Paid Partner Content | Epizyme's (EPZM) Q4 Loss Wider than Expected, Sales Beat Feb 24 / Zacks.com - Paid Partner Content |
Agios' (AGIO) Q4 Loss In Line, Revenues Surpass Estimates Feb 26 / Zacks.com - Paid Partner Content | Here's Why Bristol Myers Squibb Is Making A Mistake With Its Cash Feb 24 / MotleyFool.com - Paid Partner Content |
Previous close | 61.33 |
Today’s open | 61.76 |
Day’s range | 61.58 - 62.06 |
Volume | 4,875,486 |
Average volume (3 months) | 11,446,213 |
Market cap | $137.4B |
Earnings growth (last year) | -297.94% |
Earnings growth (this year) | +16.15% |
Earnings growth (next 5 years) | +6.76% |
Revenue growth (last year) | +62.62% |
P/E ratio | NM |
Price/Sales | 3.29 |
Price/Book | 3.64 |
Today’s change | Today’s % change | |
---|---|---|
NVONovo Nordisk | +1.75 | +2.46% |
AZNAstraZeneca | -0.09 | -0.19% |
SNYSanofi | -0.02 | -0.04% |
MRKMerck | +0.02 | +0.03% |
Next reporting date | April 29, 2021 |
EPS forecast (this quarter) | $1.81 |
Annual revenue (last year) | $42.5B |
Annual profit (last year) | -$9.0B |
Net profit margin | -21.20% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |